From cell senescence to age-related diseases: Differential mechanisms of action of senescence-associated secretory phenotypes

BMB Reports

Volumn 48, Issue 10, 2015, Pages 549-558

  Byun, Hae Ok ^a,b   Lee, Young Kyoung ^a,b   Kim, Jeong Min ^a,c   Yoon, Gyesoon ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Graduate School of Ajou Universiy   (South Korea)

^c Ajou University   (South Korea)

Author keywords

Age associated diseases; Cell senescence; Differential expression; Senescence associated secretory phenotypes (SASP)

Indexed keywords

AGE; ANIMAL; CELL AGING; GENETICS; HUMAN; PHENOTYPE; PHYSIOLOGY; SECRETORY PATHWAY;

AGE FACTORS; ANIMALS; CELL AGING; HUMANS; PHENOTYPE; SECRETORY PATHWAY;

EID: 84946234147     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2015.48.10.122     Document Type: Review

References (99)

1. Chen D, Yoo BK, Santhekadur PK et al (2011) Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma. Clin Cancer Res 17, 6693-6701
2. Jones AW, Yao Z, Vicencio JM, Karkucinska-Wieckowska A and Szabadkai G (2012) PGC-1 family coactivators and cell fate: roles in cancer, neurodegeneration, cardiovascular disease and retrograde mitochondria-nucleus signalling. Mitochondrion 12, 86-99
3. Chatrchyan S, Khachatryan V, Sirunyan AM et al (2011) Measurement of the inclusive jet cross section in pp collisions at radicals = 7 TeV. Phys Rev Lett 107, 132001
4. Sunderic M, Mihailovic N and Nedic O (2014) Protein molecular forms of insulin-like growth factor binding protein-2 change with aging. Exp Gerontol 58, 154-158
5. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H and Komuro I (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105, 1541-1544
6. Youdim MB and Riederer P (1993) The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J Neural Transm Suppl 40, 57-67
7. Hengstler JG and Bolt HM (2008) Oxidative stress: from modification of cell-cycle related events, secondary messenger function, dysregulation of small GTPases, protein kinases and phosphatases to redox-sensitive cancer models. Arch Toxicol 82, 271-272
8. Jones RM and Neef N (2012) Interpretation and prediction of inhaled drug particle accumulation in the lung and its associated toxicity. Xenobiotica 42, 86-93
9. Hung WY, Huang KH, Wu CW et al (2012) Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced beta5-integrin expression in human gastric cancer SC-M1 cells. Biochim Biophys Acta 1820, 1102-1110
10. Hoffmeister A, Ropolo A, Vasseur S et al (2002) The HMG-I/Y-related protein p8 binds to p300 and Pax2 transactivation domain-interacting protein to regulate the transactivation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter. J Biol Chem 277, 22314-22319
11. Rohman L and Jones A (2012) Chilaiditi's sign. Emerg Med J 29, 86
12. Engelberg B and Jones B (2012) Exploring minimally invasive options: managing demands, expectations, and outcomes. Dent Today 31, 86, 88, 90 passim
13. West MD, Shay JW, Wright WE and Linskens MH (1996) Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp Gerontol 31, 175-193
14. Lapierre LR and Hansen M (2012) Lessons from C. elegans: signaling pathways for longevity. Trends Endocrinol Metab 23, 637-644
15. Comi P, Chiaramonte R and Maier JA (1995) Senescencedependent regulation of type 1 plasminogen activator inhibitor in human vascular endothelial cells. Exp Cell Res 219, 304-308
16. Sabharwal SS and Schumacker PT (2014) Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nat Rev Cancer 14, 709-721
17. Ballinger SW (2013) Beyond retrograde and anterograde signalling: mitochondrial-nuclear interactions as a means for evolutionary adaptation and contemporary disease susceptibility. Biochem Soc Trans 41, 111-117
18. Dimri GP, Lee X, Basile G et al (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-9367
19. Bateman A and Bennett HP (2009) The granulin gene family: from cancer to dementia. Bioessays 31, 1245-1254
20. Beckman KB and Ames BN (1999) Endogenous oxidative damage of mtDNA. Mutat Res 424, 51-58
21. Biswas G, Adebanjo OA, Freedman BD et al (1999) Retrograde Ca2+ signaling in C2C12 skeletal myocytes in response to mitochondrial genetic and metabolic stress: a novel mode of inter-organelle crosstalk. EMBO J 18, 522-533
22. Biswas G, Anandatheerthavarada HK, Zaidi M and Avadhani NG (2003) Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol 161, 507-519
23. Berneburg M, Kamenisch Y, Krutmann J and Rocken M (2006) 'To repair or not to repair - no longer a question': repair of mitochondrial DNA shielding against age and cancer. Exp Dermatol 15, 1005-1015
24. He X, Zhou A, Lu H et al (2013) Suppression of mitochondrial complex I influences cell metastatic properties. PLoS One 8, e61677
25. Boiteux S and Radicella JP (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch Biochem Biophys 377, 1-8
26. Brandon M, Baldi P and Wallace DC (2006) Mitochondrial mutations in cancer. Oncogene 25, 4647-4662
27. Zhang YQ and Herman B (2008) Expression and modification of ARC (apoptosis repressor with a CARD domain) is distinctly regulated by oxidative stress in cancer cells. J Cell Biochem 104, 818-825
28. Bogenhagen DF, Pinz KG and Perez-Jannotti RM (2001) Enzymology of mitochondrial base excision repair. Prog Nucleic Acid Res Mol Biol 68, 257-271
29. Guettouche T, Boellmann F, Lane WS and Voellmy R (2005) Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem 6, 4
30. Butow RA and Avadhani NG (2004) Mitochondrial signaling: the retrograde response. Mol Cell 14, 1-15
31. Byun HO, Jung HJ, Seo YH et al (2012) GSK3 inactivation is involved in mitochondrial complex IV defect in transforming growth factor (TGF) beta1-induced senescence. Exp Cell Res 318, 1808-1819
32. Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM and Avadhani NG (2002) Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene 21, 7839-7849
33. Byun HO, Kim HY, Lim JJ, Seo YH and Yoon G (2008) Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production. J Cell Biochem 104, 1747-1759
34. Campagnoni CW, Landry CF, Pribyl TM et al (2001) Identification of genes in the oligodendrocyte lineage through the analysis of conditionally immortalized cell lines. Dev Neurosci 23, 452-463
35. Cano CE, Hamidi T, Sandi MJ and Iovanna JL (2011) Nupr1: the Swiss-knife of cancer. J Cell Physiol 226, 1439-1443
36. Carew JS and Huang P (2002) Mitochondrial defects in cancer. Mol Cancer 1, 9
37. Chae S, Ahn BY, Byun K et al (2013) A systems approach for decoding mitochondrial retrograde signaling pathways. Sci Signal 6, rs4
38. Chang CJ, Yin PH, Yang DM et al (2009) Mitochondrial dysfunction-induced amphiregulin upregulation mediates chemo-resistance and cell migration in HepG2 cells. Cell Mol Life Sci 66, 1755-1765
39. Chatterjee A, Mambo E and Sidransky D (2006) Mitochondrial DNA mutations in human cancer. Oncogene 25, 4663-4674
40. Stein GH and Dulic V (1998) Molecular mechanisms for the senescent cell cycle arrest. J Investig Dermatol Symp Proc 3, 14-18
41. Hwang ES, Yoon G and Kang HT (2009) A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci 66, 2503-2524
42. Cheung ST, Wong SY, Leung KL et al (2004) Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. Clin Cancer Res 10, 7629-7636
43. Chowdhury UR, Samant RS, Fodstad O and Shevde LA (2009) Emerging role of nuclear protein 1 (NUPR1) in cancer biology. Cancer Metastasis Rev 28, 225-232
44. Clayton DA (1998) Nuclear-mitochondrial intergenomic communication. Biofactors 7, 203-205
45. Cortopassi G and Wang E (1995) Modelling the effects of age-related mtDNA mutation accumulation; complex I deficiency, superoxide and cell death. Biochim Biophys Acta 1271, 171-176
46. Kim YM, Shin HT, Seo YH et al (2010) Sterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence. J Biol Chem 285, 29069-29077
47. Khachatryan V, Sirunyan AM, Tumasyan A et al (2011) Measurement of the B(+) production cross section in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett 106, 112001
48. Czarnecka AM, Kukwa W, Krawczyk T, Scinska A, Kukwa A and Cappello F (2010) Mitochondrial DNA mutations in cancer--from bench to bedside. Front Biosci 15, 437-460
49. Seo M and Lee YH (2014) PFKFB3 regulates oxidative stress homeostasis via its S-glutathionylation in cancer. J Mol Biol 426, 830-842
50. Millis AJ, Hoyle M, McCue HM and Martini H (1992) Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 201, 373-379
51. Coppe JP, Patil CK, Rodier F et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6, 2853-2868
52. Imamura H, Matsuyama Y, Tanaka E et al (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38, 200-207
53. Rodier F and Campisi J (2011) Four faces of cellular senescence. J Cell Biol 192, 547-556
54. Vital P, Castro P, Tsang S and Ittmann M (2014) The senescence-associated secretory phenotype promotes benign prostatic hyperplasia. Am J Pathol 184, 721-731
55. Han X and Boisvert WA (2015) Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Thromb Haemost 113, 505-512
56. Groppo R and Richter JD (2011) CPEB control of NF-kappaB nuclear localization and interleukin-6 production mediates cellular senescence. Mol Cell Biol 31, 2707-2714
57. Kulju KS and Lehman JM (1995) Increased p53 protein associated with aging in human diploid fibroblasts. Exp Cell Res 217, 336-345
58. Salminen A and Kaarniranta K (2010) Glycolysis links p53 function with NF-kappaB signaling: impact on cancer and aging process. J Cell Physiol 224, 1-6
59. Brookes S, Rowe J, Gutierrez Del Arroyo A, Bond J and Peters G (2004) Contribution of p16 (INK4a) to replicative senescence of human fibroblasts. Exp Cell Res 298, 549-559
60. Delsite R, Kachhap S, Anbazhagan R, Gabrielson E and Singh KK (2002) Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells. Mol Cancer 1, 6
61. Demorrow S (2013) Progranulin: a novel regulator of gastrointestinal cancer progression. Transl Gastrointest Cancer 2, 145-151
62. Di Bella D, Lazzaro F, Brusco A et al (2010) Mutations in the mitochondrial protease gene AFG3L2 cause dominant hereditary ataxia SCA28. Nat Genet 42, 313-321
63. Dzierzbicki P, Koprowski P, Fikus MU, Malc E and Ciesla Z (2004) Repair of oxidative damage in mitochondrial DNA of Saccharomyces cerevisiae: involvement of the MSH1-dependent pathway. DNA Repair (Amst) 3, 403-411
64. DiMauro S and Schon EA (2003) Mitochondrial respiratory-chain diseases. N Engl J Med 348, 2656-2668
65. Encinar JA, Mallo GV, Mizyrycki C et al (2001) Human p8 is a HMG-I/Y-like protein with DNA binding activity enhanced by phosphorylation. J Biol Chem 276, 2742-2751
66. Finley LW and Haigis MC (2009) The coordination of nuclear and mitochondrial communication during aging and calorie restriction. Ageing Res Rev 8, 173-188
67. Ashok BT, Ahmad J and Ali R (1998) Immunochemical detection of oxidative DNA damage in cancer and aging using anti-reactive oxygen species modified DNA monoclonal antibody. Int J Biochem Cell Biol 30, 1367-1377
68. Gardiner K (1995) Human genome organization. Curr Opin Genet Dev 5, 315-322
69. Goruppi S, Bonventre JV and Kyriakis JM (2002) Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J 21, 5427-5436
70. Giroux V, Malicet C, Barthet M et al (2006) p8 is a new target of gemcitabine in pancreatic cancer cells. Clin Cancer Res 12, 235-241
71. Goruppi S and Kyriakis JM (2004) The pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertrophy require NFAT4. J Biol Chem 279, 20950-20958
72. Gredilla R, Garm C and Stevnsner T (2012) Nuclear and mitochondrial DNA repair in selected eukaryotic aging model systems. Oxid Med Cell Longev 2012, 282438
73. Grollman AP and Moriya M (1993) Mutagenesis by 8-oxoguanine: an enemy within. Trends Genet 9, 246-249
74. Guha M and Avadhani NG (2013) Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion 13, 577-591
75. Takahashi T, Yoshida H, Mamada Y, Taniai N and Tajiri T (2009) Balloon-occluded retrograde transvenous obliteration for gastric varices in a child with extrahepatic portal venous obstruction. J Nippon Med Sch 76, 173-178
76. Hamidi T, Algul H, Cano CE et al (2012) Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis. J Clin Invest 122, 2092-2103
77. Hamidi T, Cano CE, Grasso D et al (2012) Nupr1-aurora kinase A pathway provides protection against metabolic stress-mediated autophagic-associated cell death. Clin Cancer Res 18, 5234-5246
78. Haque A, Nishikawa M, Qian W et al (2006) Lack of mitochondrial DNA enhances growth of hepatocellular carcinoma in vitro and in vivo. Hepatol Res 36, 209-216
79. Hashiguchi K, Stuart JA, de Souza-Pinto NC and Bohr VA (2004) The C-terminal alphaO helix of human Ogg1 is essential for 8-oxoguanine DNA glycosylase activity: the mitochondrial beta-Ogg1 lacks this domain and does not have glycosylase activity. Nucleic Acids Res 32, 5596-5608
80. Brew K, Dinakarpandian D and Nagase H (2000) Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477, 267-283
81. Reichenstein M, Reich R, LeHoux JG and Hanukoglu I (2004) ACTH induces TIMP-1 expression and inhibits collagenase in adrenal cortex cells. Mol Cell Endocrinol 215, 109-114
82. Binder BR, Christ G, Gruber F et al (2002) Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 17, 56-61
83. Alessi MC, Poggi M and Juhan-Vague I (2007) Plasminogen activator inhibitor-1, adipose tissue and insulin resistance. Curr Opin Lipidol 18, 240-245
84. Gils A and Declerck PJ (2004) The structural basis for the pathophysiological relevance of PAI-I in cardiovascular diseases and the development of potential PAI-I inhibitors. Thromb Haemost 91, 425-437
85. Schroder WA, Major L and Suhrbier A (2011) The role of SerpinB2 in immunity. Crit Rev Immunol 31, 15-30
86. Hwa V, Oh Y and Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20, 761-787
87. Stewart CE, Bates PC, Calder TA, Woodall SM and Pell JM (1993) Potentiation of insulin-like growth factor-I (IGF-I) activity by an antibody: supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133, 1462-1465
88. Clemmons DR, Busby WH, Arai T et al (1995) Role of insulin-like growth factor binding proteins in the control of IGF actions. Prog Growth Factor Res 6, 357-366
89. Orjalo AV, Bhaumik D, Gengler BK, Scott GK and Campisi J (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci U S A 106, 17031-17036
90. Kim YM, Byun HO, Jee BA et al (2013) Implications of time-series gene expression profiles of replicative senescence. Aging Cell 12, 622-634
91. Chow FL and Fernandez-Patron C (2007) Many membrane proteins undergo ectodomain shedding by proteolytic cleavage. Does one sheddase do the job on all of these proteins? IUBMB Life 59, 44-47
92. Hayashida K, Bartlett AH, Chen Y and Park PW (2010) Molecular and cellular mechanisms of ectodomain shedding. Anat Rec (Hoboken) 293, 925-937
93. Athauda G, Giubellino A, Coleman JA et al (2006) c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res 12, 4154-4162
94. Acosta JC and Gil J (2009) A role for CXCR2 in senescence, but what about in cancer? Cancer Res 69, 2167-2170
95. Freund A, Orjalo AV, Desprez PY and Campisi J (2010) Inflammatory networks during cellular senescence: causes and consequences. Trends Mol Med 16, 238-246
96. Guo H, Liu Z, Xu B et al (2013) Chemokine receptor CXCR2 is transactivated by p53 and induces p38-mediated cellular senescence in response to DNA damage. Aging Cell 12, 1110-1121
97. Kenyon C, Chang J, Gensch E, Rudner A and Tabtiang R (1993) A C. elegans mutant that lives twice as long as wild type. Nature 366, 461-464
98. Elzi DJ, Lai Y, Song M, Hakala K, Weintraub ST and Shiio Y (2012) Plasminogen activator inhibitor 1--insulin-like growth factor binding protein 3 cascade regulates stressinduced senescence. Proc Natl Acad Sci U S A 109, 12052-12057
99. Micutkova L, Diener T, Li C et al (2011) Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts. Mech Ageing Dev 132, 468-479